These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17433753)

  • 1. A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease.
    Warren L; Gibson R; Ishihara L; Elango R; Xue Z; Akkari A; Ragone L; Pahwa R; Jankovic J; Nance M; Freeman A; Watts RL; Hentati F
    Parkinsonism Relat Disord; 2008; 14(1):77-80. PubMed ID: 17433753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genealogical studies in LRRK2-associated Parkinson's disease in central Norway.
    Johansen KK; Hasselberg K; White LR; Farrer MJ; Aasly JO
    Parkinsonism Relat Disord; 2010 Sep; 16(8):527-30. PubMed ID: 20621541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
    Zabetian CP; Hutter CM; Yearout D; Lopez AN; Factor SA; Griffith A; Leis BC; Bird TD; Nutt JG; Higgins DS; Roberts JW; Kay DM; Edwards KL; Samii A; Payami H
    Am J Hum Genet; 2006 Oct; 79(4):752-8. PubMed ID: 16960813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Founder mutation p.R1441C in the leucine-rich repeat kinase 2 gene in Belgian Parkinson's disease patients.
    Nuytemans K; Rademakers R; Theuns J; Pals P; Engelborghs S; Pickut B; de Pooter T; Peeters K; Mattheijssens M; Van den Broeck M; Cras P; De Deyn PP; van Broeckhoven C
    Eur J Hum Genet; 2008 Apr; 16(4):471-9. PubMed ID: 18197194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
    Lesage S; Patin E; Condroyer C; Leutenegger AL; Lohmann E; Giladi N; Bar-Shira A; Belarbi S; Hecham N; Pollak P; Ouvrard-Hernandez AM; Bardien S; Carr J; Benhassine T; Tomiyama H; Pirkevi C; Hamadouche T; Cazeneuve C; Basak AN; Hattori N; Dürr A; Tazir M; Orr-Urtreger A; Quintana-Murci L; Brice A;
    Hum Mol Genet; 2010 May; 19(10):1998-2004. PubMed ID: 20197411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
    Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
    Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century.
    Lesage S; Leutenegger AL; Ibanez P; Janin S; Lohmann E; Dürr A; Brice A;
    Am J Hum Genet; 2005 Aug; 77(2):330-2. PubMed ID: 16145815
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families.
    Ishihara L; Gibson RA; Warren L; Amouri R; Lyons K; Wielinski C; Hunter C; Swartz JE; Elango R; Akkari PA; Leppert D; Surh L; Reeves KH; Thomas S; Ragone L; Hattori N; Pahwa R; Jankovic J; Nance M; Freeman A; Gouider-Khouja N; Kefi M; Zouari M; Ben Sassi S; Ben Yahmed S; El Euch-Fayeche G; Middleton L; Burn DJ; Watts RL; Hentati F
    Mov Disord; 2007 Jan; 22(1):55-61. PubMed ID: 17115391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.
    Mata IF; Hutter CM; González-Fernández MC; de Pancorbo MM; Lezcano E; Huerta C; Blazquez M; Ribacoba R; Guisasola LM; Salvador C; Gómez-Esteban JC; Zarranz JJ; Infante J; Jankovic J; Deng H; Edwards KL; Alvarez V; Zabetian CP
    Neurogenetics; 2009 Oct; 10(4):347-53. PubMed ID: 19308469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evolution of Genetic Variability at the
    Guenther DT; Follett J; Amouri R; Sassi SB; Hentati F; Farrer MJ
    Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
    Di Fonzo A; Rohé CF; Ferreira J; Chien HF; Vacca L; Stocchi F; Guedes L; Fabrizio E; Manfredi M; Vanacore N; Goldwurm S; Breedveld G; Sampaio C; Meco G; Barbosa E; Oostra BA; Bonifati V;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):412-5. PubMed ID: 15680456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
    Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
    Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 mutations in a clinic-based cohort of Parkinson's disease.
    Scholz S; Mandel RJ; Fernandez HH; Foote KD; Rodriguez RL; Barton E; Munson S; Singleton A; Okun MS
    Eur J Neurol; 2006 Dec; 13(12):1298-301. PubMed ID: 17116211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.